Research | OneLook Acronym Finder |
Serial Number | 79356463 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2022-08-10 | Application Filed |
2022-12-02 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2022-12-02 | Status: Live/Pending |
2022-12-05 | Transaction Date |
Owner: | Genmab A/S |
Address | Kalvebod Brygge 43 DK-1560 København V DK |
Legal Entity Type | |
Legal Entity State | DK |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 45 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases |
GS0051 | Pharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disorders |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-12-02 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-12-05 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-12-09 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2023-03-13 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2023-03-14 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-03-15 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2023-05-03 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-05-04 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2023-05-24 | 9 RFNP P: |
CHANGE OF NAME/ADDRESS REC'D FROM IB | 2023-09-15 | 10 ADCH M: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-10-06 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-10-06 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-10-07 | 13 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-10-12 | 14 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-10-25 | 15 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2023-11-14 | 16 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-11-14 | 17 NPUB E:E-Mail |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-01-15 | 18 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-01-15 | 19 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2024-01-15 | 20 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-01-15 | 21 TCCA I:Incoming Correspondence |
REGISTERED-PRINCIPAL REGISTER | 2024-01-30 | 22 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-01-30 | 23 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-04-30 | 24 FICR P: |
FINAL DISPOSITION PROCESSED | 2024-04-30 | 25 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2024-05-01 | 26 FICS P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.